Selective Transduction of HIV-1-Infected Cells by the Combination of HIV and MMLV Vectors
- 29 Downloads
Human immunodeficiency virus 1 (HIV-1)-infected cells are important targets of gene therapy for acquired immune deficiency syndrome. We have developed a novel strategy for targeted gene transfer into HIV-1-infected cells based on 2-step gene transfer. The first step involves the stable introduction of the HIV vector containing the ecotropic Moloney murine leukemia virus (MMLV) receptor gene (EcoRec) into human CD4+ T cells as a molecular switch. Because the HIV-long terminal repeat (HIV-LTR) is Tat inducible, it is expected that EcoRec is expressed only after HIV-1 infection. Northern blot analysis and a retrovirus binding assay confirmed that the HIV-LTR of the integrated vector was silent in transduced cells but strongly transactivated in HIV-1 infection. High levels of EcoRec expression were observed only in HIV-1-infected cells. These cells became highly susceptible to ecotropic MMLV infection and, therefore, in the second step, HIV-1-infected cells were selectively transduced with ecotropic MMLV vectors. More than 70% of HIV-1-infected cells were transduced by this strategy. These findings indicate that this 2-step method can be used for selective and stable gene transfer into HIV-1-infected cells.
Key wordsGene therapy Viral vectors Targeting HIV-1 infection
Unable to display preview. Download preview PDF.
- 3.Amado RG, Mitsuyasu RT, Zack JA. Gene therapy for the treatment of AIDS: animal models and human clinical experience.Front Biosci. 1999;4:468–475.Google Scholar
- 12.Marin M, Noel D, Valsesia-Wittman S, et al. Targeted infection of human cells via major histocompatibility complex class I molecules by moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.J Virol. 1996;70:2957–2962.PubMedPubMedCentralGoogle Scholar
- 15.Schnierle BS, Groner B. Retroviral targeted delivery.Gene Ther. 1996;3:1069–1073.Google Scholar
- 16.Cosset F-L, Russell SJ. Targeting retrovirus entry.Gene Ther. 1996;3:946–956.Google Scholar
- 18.Fujii I, Suzuki S, Igarashi T, Matsukura M, Miike T, Shimada T. Targeted and stable gene delivery into muscle cells by a two-step transfer system.Biochem Biophys Res Commun. 2000;13:615–618.Google Scholar
- 23.Bertran J, Miller JL, Yang Y, et al. Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors.J Virol. 1996;70:6759–6766.PubMedPubMedCentralGoogle Scholar